000078.SZ
Shenzhen Neptunus Bioengineering Co., Ltd.
SZSE · Healthcare · F 批发零售 · CN
CNY 1.59
−1.85%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 1.51
From 52W high−69.94%
Volume52.80M
Market capCNY 4.18B
P/E (TTM)−7.4x
P/S (TTM)0.2x
Div yield—
Key dataSep 18, 2026
Open
CNY 1.51
From 52W high
−69.94%
Volume
52.80M
Market cap
CNY 4.18B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−37.0x
P/E (TTM)
−7.4x
RSI (14)
45.6
MomentumView details →
1D Return
−1.85%
YTD Return
−56.07%
Similar companies
Latest newsMore news →
ST Haiwang reported first-half 2026 revenue of about 11.299 billion yuan, down 21.05% year on year, and a net loss attributable to shareholders of about 204 million yuan, swinging from profit to loss.6d agoShenzhen Haiwang Nutrition Intelligent Computing Co., Ltd. was established, jointly held by ST Haiwang and others, with a business scope including internet data services and AI application software development.11d agoST Haiwang disclosed that its controlling shareholder Haiwang Group formed disguised fund occupation of 1.256 billion yuan, with a rectification plan to repay by end of 2026.24d ago